Wellbiotec Co. Ltd. Net Assets
Wellbiotec Co. Ltd. net assets. Based on the latest financial reports, Wellbiotec Co. Ltd. (010600) has net assets worth ₩20.18 Billion KRW (≈ $13.68 Million USD) as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩31.95 Billion ≈ $21.65 Million USD) and total liabilities (₩11.76 Billion ≈ $7.97 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Wellbiotec Co. Ltd. annual equity growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩20.18 Billion |
| % of Total Assets | 63.18% |
| Annual Growth Rate | -3.27% |
| 5-Year Change | 3.56% |
| 10-Year Change | -44.81% |
| Growth Volatility | 47.22 |
Net Assets of Wellbiotec Co. Ltd. (2002–2024)
Net assets of Wellbiotec Co. Ltd. from 2002 to 2024. This chart illustrates how Wellbiotec Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. See net asset quality index of Wellbiotec Co. Ltd. to measure how much of total assets are equity-financed.
Annual Net Assets for Wellbiotec Co. Ltd. (2002–2024)
The table below shows the annual net assets of Wellbiotec Co. Ltd. from 2002 to 2024. For live market cap and overall valuation, see 010600 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩20.18 Billion ≈ $13.68 Million |
-45.77% |
| 2023-12-31 | ₩37.22 Billion ≈ $25.22 Million |
-1.53% |
| 2022-12-31 | ₩37.80 Billion ≈ $25.61 Million |
+13.48% |
| 2021-12-31 | ₩33.31 Billion ≈ $22.57 Million |
+70.89% |
| 2020-12-31 | ₩19.49 Billion ≈ $13.21 Million |
-74.23% |
| 2019-12-31 | ₩75.64 Billion ≈ $51.26 Million |
-1.00% |
| 2018-12-31 | ₩76.40 Billion ≈ $51.78 Million |
+184.55% |
| 2017-12-31 | ₩26.85 Billion ≈ $18.20 Million |
-20.70% |
| 2016-12-31 | ₩33.86 Billion ≈ $22.95 Million |
-7.42% |
| 2015-12-31 | ₩36.57 Billion ≈ $24.78 Million |
+4.13% |
| 2014-12-31 | ₩35.12 Billion ≈ $23.80 Million |
-13.68% |
| 2013-12-31 | ₩40.69 Billion ≈ $27.57 Million |
+12.90% |
| 2012-12-31 | ₩36.04 Billion ≈ $24.42 Million |
-9.16% |
| 2011-12-31 | ₩39.68 Billion ≈ $26.89 Million |
+5.41% |
| 2010-12-31 | ₩37.64 Billion ≈ $25.51 Million |
+16.03% |
| 2009-12-31 | ₩32.44 Billion ≈ $21.98 Million |
-31.37% |
| 2008-12-31 | ₩47.27 Billion ≈ $32.03 Million |
+14.01% |
| 2007-12-31 | ₩41.46 Billion ≈ $28.10 Million |
+0.18% |
| 2006-12-31 | ₩41.38 Billion ≈ $28.04 Million |
+9.15% |
| 2005-12-31 | ₩37.91 Billion ≈ $25.69 Million |
+5.81% |
| 2004-12-31 | ₩35.83 Billion ≈ $24.28 Million |
+2.68% |
| 2003-12-31 | ₩34.90 Billion ≈ $23.65 Million |
-16.79% |
| 2002-12-31 | ₩41.94 Billion ≈ $28.42 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Wellbiotec Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18536224587000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Wellbiotec Co. Ltd. Net Assets Breakdown (December 2024)
Wellbiotec Co. Ltd. net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩205.55 Billion | 1018.40% |
| Total Equity | ₩20.18 Billion | 100.00% |
Wellbiotec Co. Ltd. Competitors by Market Cap
The table below lists competitors of Wellbiotec Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SHL Telemedicine Ltd American Depositary Shares
NASDAQ:SHLT
|
$33.60 Million |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
$33.62 Million |
|
Topmix Berhad
KLSE:0302
|
$33.62 Million |
|
Fridenson
TA:FRDN
|
$33.64 Million |
|
Asia Plastic Recycling Holding Ltd
TW:1337
|
$33.56 Million |
|
Peoplein Ltd
AU:PPE
|
$33.55 Million |
|
Jinli Group Holdings Ltd
TW:8429
|
$33.53 Million |
|
Enapter AG
F:H2O
|
$33.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wellbiotec Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 38,006,125,770 to 20,183,065,200, a change of -17,823,060,570 (-46.9%).
- Net loss of 21,219,760,990 reduced equity.
- Other factors increased equity by 3,396,700,420.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-21.22 Billion | -105.14% |
| Other Changes | ₩3.40 Billion | +16.83% |
| Total Change | ₩- | -46.90% |
Book Value vs Market Value Analysis
This analysis compares Wellbiotec Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.33x to 2.46x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩1669.73 | ₩545.00 | x |
| 2018-12-31 | ₩2020.34 | ₩545.00 | x |
| 2019-12-31 | ₩1774.11 | ₩545.00 | x |
| 2020-12-31 | ₩419.04 | ₩545.00 | x |
| 2021-12-31 | ₩559.36 | ₩545.00 | x |
| 2022-12-31 | ₩560.93 | ₩545.00 | x |
| 2023-12-31 | ₩418.00 | ₩545.00 | x |
| 2024-12-31 | ₩221.98 | ₩545.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wellbiotec Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -105.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -25.47%
- • Asset Turnover: 2.61x
- • Equity Multiplier: 1.58x
- Recent ROE (-105.14%) is below the historical average (-44.65%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 9.23% | 2.12% | 1.57x | 2.77x | ₩-278.67 Million |
| 2003 | 4.13% | 0.71% | 1.51x | 3.85x | ₩-1.84 Billion |
| 2004 | 9.58% | 1.52% | 1.61x | 3.90x | ₩-140.48 Million |
| 2005 | 3.33% | 0.54% | 1.40x | 4.42x | ₩-2.28 Billion |
| 2006 | 6.64% | 1.05% | 1.54x | 4.11x | ₩-1.19 Billion |
| 2011 | 4.32% | 1.42% | 1.68x | 1.80x | ₩-2.24 Billion |
| 2013 | 5.95% | 1.75% | 2.25x | 1.52x | ₩-1.63 Billion |
| 2014 | -19.06% | -5.56% | 1.95x | 1.75x | ₩-10.15 Billion |
| 2015 | 1.51% | 0.49% | 1.90x | 1.62x | ₩-3.09 Billion |
| 2016 | -7.28% | -2.87% | 1.42x | 1.78x | ₩-5.82 Billion |
| 2017 | -34.33% | -12.35% | 0.81x | 3.42x | ₩-11.29 Billion |
| 2018 | -20.85% | -21.05% | 0.67x | 1.49x | ₩-23.03 Billion |
| 2019 | -20.05% | -18.25% | 0.70x | 1.57x | ₩-22.93 Billion |
| 2020 | -355.15% | -111.58% | 0.85x | 3.74x | ₩-69.33 Billion |
| 2021 | -59.76% | -16.13% | 0.89x | 4.17x | ₩-22.90 Billion |
| 2022 | -56.04% | -13.21% | 2.63x | 1.62x | ₩-24.61 Billion |
| 2023 | -170.79% | -108.64% | 0.99x | 1.59x | ₩-68.71 Billion |
| 2024 | -105.14% | -25.47% | 2.61x | 1.58x | ₩-23.24 Billion |
Industry Comparison
This section compares Wellbiotec Co. Ltd.'s net assets metrics with peer companies in the Textile Manufacturing industry.
Industry Context
- Industry: Textile Manufacturing
- Average net assets among peers: $296,449,401,378
- Average return on equity (ROE) among peers: 0.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wellbiotec Co. Ltd. (010600) | ₩20.18 Billion | 9.23% | 0.58x | $33.58 Million |
| Kyungbangco.Ltd (000050) | $629.70 Billion | 0.00% | 1.15x | $129.00 Million |
| Chonbang (000950) | $236.56 Billion | 0.00% | 1.20x | $23.47 Million |
| Silla Textile Co.Ltd (001000) | $15.39 Billion | -0.23% | 1.07x | $6.91 Million |
| Taihan Textile (001070) | $126.08 Billion | -12.37% | 0.57x | $12.90 Million |
| DI Dong Il Corp (001530) | $561.11 Billion | 0.00% | 0.64x | $320.18 Million |
| Ilshin Spinnin (003200) | $694.22 Billion | 2.86% | 0.30x | $151.57 Million |
| Pang Rim Spinn (003610) | $152.24 Billion | 2.01% | 0.47x | $125.75 Million |
| Daehan Synthet (003830) | $398.08 Billion | 1.26% | 0.27x | $76.95 Million |
| Duksung (004830) | $85.77 Billion | 6.57% | 0.48x | $27.41 Million |
| Duksung Co Ltd (004835) | $65.34 Billion | 0.80% | 0.61x | $4.15 Million |
About Wellbiotec Co. Ltd.
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and spe… Read more